Hostname: page-component-76fb5796d-r6qrq Total loading time: 0 Render date: 2024-04-25T13:58:37.725Z Has data issue: false hasContentIssue false

Physicians' Preferences in a Blind Trial of Imipramine and Amitriptyline

Published online by Cambridge University Press:  29 January 2018

Evelyn Reynolds
Affiliation:
Department of Pharmacology, The London Hospital Medical College, Turner Street E.1; now at Department of Psychology, West Ham College of Technology, Romford Road, London, E.15
D. F. Craggs
Affiliation:
Department of Psychiatry, The London Hospital, E.1; now at Hellingly Hospital, Hailsham, Sussex
M. P. Joyston-Bechal
Affiliation:
Department of Psychological Medicine, The London Hospital, E.1; now at Shenley Hospital, near St. Albans, Herts
M. J. Pritchard
Affiliation:
Department of Psychiatry, The London Hospital Medical College, Turner Street, E.1
P. H. Tooley
Affiliation:
Department of Psychiatry, The London Hospital, E.1
M. Weatherall
Affiliation:
Department of Pharmacology, The London Hospital Medical College, Turner Street, E.1; now at The Wellcome Research Laboratories, Beckenham, Kent

Extract

Some investigations suggest that the attitude of a psychiatrist to therapy with drugs may affect his patient's response to treatment (Sheard, 1963; Reynolds, Joyce, Swift, Tooley and Weatherall, 1965), though the evidence is far from conclusive and earlier findings have not always been confirmed by further research (Hordern and Hamilton, 1963; Uhlenhuth and Park, 1964). The possibility that a particular drug may be more effective if administered by a physician who believes it to be superior to alternative drugs appears to have received little attention. Such preferences exist in medical practice. The present study was undertaken to test the hypothesis that they have a measurable effect, provided the drug is administered knowingly. The efficacy of the drug of choice of three psychiatrists was therefore compared (a) under single blind and double blind conditions, and (b) with that of alternative medication.

Type
Research Article
Copyright
Copyright © Royal College of Psychiatrists, 1969 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Hare, E. H., McCance, C., McCormick, W. O. (1964). “Imipramine and ‘Drinamyl’ in depressive illness: a comparative trial.” Brit. med. J., i, 818820.CrossRefGoogle Scholar
Hordern, A., and Hamilton, M. (1963). “Drugs and ‘moral treatment’.” Brit. J. Psychiat., 109, 500509.Google Scholar
Hordern, A., Holt, N. F., Burt, C. G., and Gordon, W. F. (1963). “Amitriptyline in depressive states.” Brit. J. Psychiat., 109, 815825.Google Scholar
Klerman, G. L., and Cole, J. O. (1965). “Clinical pharmacology of imipramine and related antidepressant compounds.” Pharmacol. Rev., 17, 101141.Google Scholar
Reynolds, E., Joyce, C. R. B., Swift, J. L., Tooley, P. H., and Weatherall, M. (1965). “Psychological and clinical investigation of the treatment of anxious outpatients with three barbiturates and placebo.” Brit. J. Psychiat., 111, 8495.Google Scholar
Schachter, S. (1966). “The interaction of cognitive and physiological determinants of emotional state.” In: Anxiety and Behaviour (ed. Spielberger, C. D.). New York: Academic Press, pp. 193224.Google Scholar
Sheard, M. H. (1963). “The influence of doctor's attitude on the patient's response to antidepressant medication.” J. nerv. ment. Dis., 136, 555560.Google Scholar
Uhlenhuth, E. H., and Park, L. C. (1964). “The influence of medication (imipramine) and doctor in relieving depressed psychoneurotic outpatients.” J. psychiat. Res., 2, 101122.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.